Reported positive interim pharmacokinetic ("PK") and safety data in Phase 1 trial of SPY001 in November 2024 and strengthened the balance sheet with a $230 million ...

Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and tr ...

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...

Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that ...

The IVDR certification allows the company to pursue market expansion within Europe's in vitro diagnostic market.

Scarring is expected after most operations, but surgical adhesions present a unique challenge for patients and surgeons.

• Azathioprine and 6-mercaptopurine seem to be more effective than placebo (fake pills) for the long-term treatment of ulcerative colitis, which is an inflammatory disorder of the large bowel. • There ...

A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...

Daniela Soto, 25, lives in Los Angeles and was diagnosed with ulcerative colitis (UC) when she was just 21. If you don’t know ...

A clinical study is underway that is testing whether an investigational medicine is safe and whether it may work to help ...

The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.

Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...